Healthcare -
Biotechnology - NASDAQ - US
$ 0.0001
0 %
$ 5.45 K
Market Cap
0.0
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
41.42%
Net Income
Estimate
48.36%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Better Therapeutics, Inc.
BTTX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart BTTX
EBIT FORECAST
EBIT Forecast Chart BTTX
NET INCOME FORECAST
Net Income Chart BTTX